Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
- About 550 patients will be treated once weekly for 12 weeks STAR-1 topline results expected in first quarter of 2025 Acne affects about 50 million patients in the U.S. -SAN DIEGO, CA / ACCESSWIRE / December 20, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company&q.
DTCC Introduces OTC Direct Connect To Provide Access To Derivatives Transactions Data crowdfundinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crowdfundinsider.com Daily Mail and Mail on Sunday newspapers.
OTC Direct Connect will improve data access for OTC derivatives trades reported to DTCC’s Data Repository, using AWS Data Exchange to reference trade data held in AWS cloud